| Features: |
| Silver NanoParticles Summary: 1. Smaller sizes desirable due to greater surface area, and cell penetration (enhanced permeability and retention (EPR) effect) 2. Two main types: AgNP and silver ions (big debate on uses: Ag+ turning to AgCl in stomach but AgCl also effective. Take sodium-bicarbonate? 3. Dose example 80kg person: 1.12-2mg/day, which can be calculated based on ppm and volume taken (see below) target < 10ppm and 120mL per day (30ppm and 1L per day caused argyria 30mg/day ) (Case Report: 9‐15 ppm@120mL, i.e. 1.1mg/L to 1.8mg/L per day) Likely 10ppm --> 10mg/L, hence if take 100mL, then 1mg/day? (for Cancer) The current Rfd for oral silver exposure is 5 ug/kg/d with a critical dose estimated at 14 ug/kg/d for the average person. Seems like the Cancer target range is 14ug/kg/day to 25ug/kg/day. 80Kg example: 1.12mg to 2mg “1.4µg/kg body weight. If I would have 70kg, I would want to use 100µg/day. However, for fighting active disease, I would tend to explore higher daily dose, as I think this may be too low.” 4. AntiOxidants/NAC can counter act the effect of Silver NanoParticles from producing reactive oxygen species (ROS) and mitochondrial damage . NAC is a supplement form of cysteine, an amino acid that helps make glutathione, a powerful antioxidant. 5. In vitro most reports indicate AgNPs increase ROS in both cancer and normal cell (but in vivo improved antioxidant system of normal may create selectivity) 6. Pathways/mechanisms of action/: -” intracellular ROS was increased...reduction in levels of glutathione (GSH)” -”AgNPs affect the function of the vascular endothelial growth factor (VEGF)” (likely reducing levels) -”expression of BAX and BCL2 genes was increased” -”upregulation of proapoptotic genes (p53, p21, Bax, and caspases) and downregulation of antiapoptotic genes (Bcl-2)” -” upregulation of AMPK and downregulation of mTOR, MMP-9, BCL-2, and α-SMA” -”p53 is a key player...proapoptotic genes p53 and Bax were significantly increased... noticeable reduction in Bcl-2 transcript levels” -” p53 participates directly in the intrinsic apoptosis pathway by regulating the mitochondrial outer membrane permeabilization” - “Proapoptotic markers (BAX/BCL-XL, cleaved poly(ADP-ribose) polymerase, p53, p21, and caspases 3, 8 and 9) increased.” -”The antiapoptotic markers, AKT and NF-kB, decreased in AgNP-treated cells.” Silver NanoParticles and Magnetic Fields Summary: 1. “exposure to PMF increased the ability of AgNPs uptake” 2. 6x improvement from AgNPs alone could glucose capping of SilverNPs work as trojan horse? Sodium selenite might protect against toxicity of AgNPs in normal cells. -uncoated AgNPs can degrade the gut microbiome. PVP, citrate, green-synthesized, chitosan coating, may reduce the effect. Also may be true for Selenium(Sodium selenite) becuase of antioxidant properties, slowing oxidation of Ag0 to Ag+. co-ingestion with food (higher pH) favors reduction and lower Ag+ levels. -action mechanisms of AgNPs: the release of silver ions (Ag+), generation of reactive oxygen species (ROS), destruction of membrane structure. |
| 3579- | CUR, | SNP, | Metal–Curcumin Complexes in Therapeutics: An Approach to Enhance Pharmacological Effects of Curcumin |
| - | Review, | NA, | NA |
| 664- | EGCG, | SNP, | Epigallocatechin-3-gallate-capped Ag nanoparticles: preparation and characterization |
| - | Analysis, | NA, | NA |
| 2833- | FIS, | SNP, | Glucose-capped fisetin silver nanoparticles induced cytotoxicity and ferroptosis in breast cancer cells: A molecular perspective |
| - | in-vitro, | BC, | MDA-MB-231 |
| 1904- | GoldNP, | SNP, | Unveiling the Potential of Innovative Gold(I) and Silver(I) Selenourea Complexes as Anticancer Agents Targeting TrxR and Cellular Redox Homeostasis |
| - | in-vitro, | Lung, | H157 | - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Colon, | HCT15 | - | in-vitro, | Melanoma, | A375 |
| 848- | Gra, | SNP, | Synthesis, Characterization and Evaluation of Antioxidant and Cytotoxic Potential of Annona muricata Root Extract-derived Biogenic Silver Nanoparticles |
| - | in-vitro, | CRC, | HCT116 |
| 854- | Gra, | SNP, | Green Synthesis of Silver Nanoparticles Using Annona muricata Extract as an Inducer of Apoptosis in Cancer Cells and Inhibitor for NLRP3 Inflammasome via Enhanced Autophagy |
| - | vitro+vivo, | AML, | THP1 | - | in-vitro, | AML, | AMJ13 | - | vitro+vivo, | lymphoma, | HBL |
| 853- | Gra, | SNP, | Solid lipid nanoparticles of Annona muricata fruit extract: formulation, optimization and in vitro cytotoxicity studies |
| 861- | Lae, | Chit, | SNP, | Synthesis of polygonal chitosan microcapsules for the delivery of amygdalin loaded silver nanoparticles in breast cancer therapy |
| 323- | Sal, | SNP, | Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Ovarian, | A2780S |
| 4440- | Se, | SNP, | Selenium, silver, and gold nanoparticles: Emerging strategies for hepatic oxidative stress and inflammation reduction |
| - | Review, | NA, | NA |
| 4539- | SNP, | VitC, | Citrate, | Investigating the Anti-cancer Potential of Silver Nanoparticles Synthesized by Chemical Reduction of AgNO3 Using Trisodium Citrate and Ascorbic Acid |
| - | in-vitro, | Nor, | L929 | - | in-vitro, | Ovarian, | SKOV3 |
| 4547- | SNP, | GoldNP, | VitC, | Exploration of Biocompatible Ascorbic Acid Reduced and Stabilized Gold Nanoparticles, as Sensitive and Selective Detection Nanoplatform for Silver Ion in Solution |
| - | Study, | NA, | NA |
| 4546- | SNP, | Chapter 2 - Silver nanoparticles in cancer therapy |
| - | Study, | Var, | NA |
| 4545- | SNP, | VitC, | Citrate, | Ascorbic Acid-assisted Green Synthesis of Silver Nanoparticles: pH and Stability Study |
| - | Study, | NA, | NA |
| 4544- | SNP, | VitC, | Current Research on Silver Nanoparticles: Synthesis, Characterization, and Applications |
| - | Review, | Nor, | NA |
| 4543- | SNP, | Biogenic synthesis of silver nanoparticles using Zaleya pentandra and investigation of their biological activities |
| - | Study, | Nor, | NA |
| 4542- | SNP, | Silver Nanoparticles (AgNPs): Comprehensive Insights into Bio/Synthesis, Key Influencing Factors, Multifaceted Applications, and Toxicity─A 2024 Update |
| - | Review, | NA, | NA |
| 4541- | SNP, | RosA, | Eco-friendly synthesis of silver nanoparticles: multifaceted antioxidant, antidiabetic, anticancer, and antimicrobial activities |
| - | in-vitro, | Nor, | WI38 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | PC, | PANC1 |
| 4540- | SNP, | VitC, | Silver nanoparticles from ascorbic acid: Biosynthesis, characterization, in vitro safety profile, antimicrobial activity and phytotoxicity |
| - | in-vitro, | Nor, | NA |
| - | in-vitro, | BC, | MCF-7 |
| 4447- | SNP, | Anti-inflammatory action of silver nanoparticles in vivo: systematic review and meta-analysis |
| - | Review, | Nor, | NA |
| 4439- | SNP, | Anticancer Potential of Green Synthesized Silver Nanoparticles Using Extract of Nepeta deflersiana against Human Cervical Cancer Cells (HeLA) |
| - | in-vitro, | Cerv, | HeLa |
| 4438- | SNP, | ART/DHA, | Biogenic synthesis of AgNPs using Artemisia oliveriana extract and their biological activities for an effective treatment of lung cancer |
| - | in-vitro, | Lung, | A549 |
| 4437- | SNP, | Green Fabrication of silver nanoparticles by leaf extract of Byttneria Herbacea Roxb and their promising therapeutic applications and its interesting insightful observations in oral cancer |
| - | in-vitro, | Oral, | NA |
| 4436- | SNP, | Silver Nanoparticles (AgNPs) as Enhancers of Everolimus and Radiotherapy Sensitivity on Clear Cell Renal Cell Carcinoma |
| - | in-vitro, | Kidney, | 786-O |
| 4435- | SNP, | Gluc, | Glucose-Functionalized Silver Nanoparticles as a Potential New Therapy Agent Targeting Hormone-Resistant Prostate Cancer cells |
| - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | DU145 |
| 4556- | SNP, | Biofilm Impeding AgNPs Target Skin Carcinoma by Inducing Mitochondrial Membrane Depolarization Mediated through ROS Production |
| - | in-vitro, | Melanoma, | A431 |
| 4564- | SNP, | GoldNP, | Cu, | Chemo, | PDT | Cytotoxicity and targeted drug delivery of green synthesized metallic nanoparticles against oral Cancer: A review |
| - | Review, | Var, | NA |
| 4563- | SNP, | Rad, | Silver nanoparticles enhance neutron radiation sensitivity in cancer cells: An in vitro study |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Ovarian, | SKOV3 | - | in-vitro, | GBM, | U87MG | - | in-vitro, | Melanoma, | A431 |
| 4562- | SNP, | VitC, | Eco-friendly Synthesis of Silver Nanoparticles using Ascorbic Acid and its Optical Characterization |
| - | Study, | NA, | NA |
| 4561- | SNP, | VitC, | Cellular Effects Nanosilver on Cancer and Non-cancer Cells: Potential Environmental and Human Health Impacts |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Nor, | HEK293 |
| 4560- | SNP, | Exploiting antidiabetic activity of silver nanoparticles synthesized using Punica granatum leaves and anticancer potential against human liver cancer cells (HepG2) |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Diabetic, | NA |
| 4559- | SNP, | Anticancer activity of biogenerated silver nanoparticles: an integrated proteomic investigation |
| - | in-vitro, | BC, | SkBr3 | - | in-vitro, | CRC, | HT-29 | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Colon, | Caco-2 |
| 4558- | SNP, | Role of Oxidative and Nitro-Oxidative Damage in Silver Nanoparticles Cytotoxic Effect against Human Pancreatic Ductal Adenocarcinoma Cells |
| - | in-vitro, | PC, | PANC1 |
| 4557- | SNP, | The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells |
| - | in-vitro, | NA, | NIH-3T3 | - | in-vitro, | CRC, | HCT116 |
| - | vitro+vivo, | Nor, | NA |
| 4555- | SNP, | Silver nanoparticles from Dendropanax morbifera Léveille inhibit cell migration, induce apoptosis, and increase generation of reactive oxygen species in A549 lung cancer cells |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Liver, | HepG2 |
| 4554- | SNP, | Involvement of telomerase activity inhibition and telomere dysfunction in silver nanoparticles anticancer effects |
| - | in-vitro, | Cerv, | HeLa |
| 4553- | SNP, | Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types |
| - | in-vitro, | Nor, | RAW264.7 |
| 4552- | SNP, | ART/DHA, | Green synthesis of silver nanoparticles using Artemisia turcomanica leaf extract and the study of anti-cancer effect and apoptosis induction on gastric cancer cell line (AGS) |
| - | in-vitro, | GC, | AGS |
| 4551- | SNP, | Fenb, | Ångstrom-Scale Silver Particles as a Promising Agent for Low-Toxicity Broad-Spectrum Potent Anticancer Therapy |
| - | in-vivo, | Lung, | NA |
| 4550- | SNP, | The Effect of Charge at the Surface of Silver Nanoparticles on Antimicrobial Activity against Gram-Positive and Gram-Negative Bacteria: A Preliminary Study |
| - | Study, | Nor, | NA |
| 4549- | SNP, | Silver nanoparticles: Synthesis, medical applications and biosafety |
| - | Review, | Var, | NA | - | Review, | Diabetic, | NA |
| 4406- | SNP, | Silver nanoparticles achieve cytotoxicity against breast cancer by regulating long-chain noncoding RNA XLOC_006390-mediated pathway |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | T47D | - | in-vitro, | BC, | MDA-MB-231 |
| 4414- | SNP, | Silver nanoparticles: Forging a new frontline in lung cancer therapy |
| - | Review, | Lung, | NA |
| 4413- | SNP, | Anzaroot, | Green synthesis of silver nanoparticles from plant Astragalus fasciculifolius Bioss and evaluating cytotoxic effects on MCF7 human breast cancer cells |
| - | in-vitro, | BC, | MCF-7 |
| 4412- | SNP, | Biosynthesis and characterization of silver nanoparticles from Asplenium dalhousiae and their potential biological properties |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Melanoma, | A2780S |
| 4411- | SNP, | Eco-friendly synthesis of silver nanoparticles using Anemone coronaria bulb extract and their potent anticancer and antibacterial activities |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | Pca, | PC3 | - | in-vitro, | Nor, | HEK293 |
| 4410- | SNP, | Green-synthesized silver nanoparticles: a sustainable nanoplatform for targeted colon cancer therapy |
| - | Review, | Colon, | NA |
| 4409- | SNP, | Plant-based synthesis of gold and silver nanoparticles using Artocarpus heterophyllus aqueous leaf extract and its anticancer activities |
| - | in-vitro, | BC, | MCF-7 |
| 4408- | SNP, | Chitosan-coated silver nanoparticles synthesized using Moringa oleifera flower extract: A potential therapeutic approach against triple-negative breast cancer |
| - | in-vitro, | BC, | MDA-MB-231 |
| 4407- | SNP, | Green Synthesis and Characterization of Silver Nanoparticles from Eclipta alba and Its Activity Against Triple-Negative Breast Cancer Cell Line (MDA-MB-231) |
| - | in-vitro, | BC, | MDA-MB-231 |
| 4415- | SNP, | SDT, | CUR, | Examining the Impact of Sonodynamic Therapy With Ultrasound Wave in the Presence of Curcumin-Coated Silver Nanoparticles on the Apoptosis of MCF7 Breast Cancer Cells |
| - | in-vitro, | BC, | MCF-7 |
| 4405- | SNP, | Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis |
| - | in-vitro, | OS, | NA |
| 4404- | SNP, | Rad, | Main Approaches to Enhance Radiosensitization in Cancer Cells by Nanoparticles: A Systematic Review |
| - | Review, | Var, | NA |
| 4403- | SNP, | Silver Nanoparticles Decorated UiO-66-NH2 Metal-Organic Framework for Combination Therapy in Cancer Treatment |
| - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | GL26 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | CRC, | RKO |
| 4402- | SNP, | Enhancement of Triple-Negative Breast Cancer-Specific Induction of Cell Death by Silver Nanoparticles by Combined Treatment with Proteotoxic Stress Response Inhibitors |
| - | in-vitro, | BC, | BT549 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF10 |
| 4401- | SNP, | Rad, | Metformin-loaded chitosan nanoparticles augment silver nanoparticle-induced radiosensitization in breast cancer cells during radiation therapy |
| - | in-vitro, | BC, | NA |
| 4400- | SNP, | Rad, | Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Nor, | MCF10 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | BT549 | - | in-vivo, | BC, | MDA-MB-231 |
| 4399- | SNP, | Chit, | Silver nanoparticles impregnated alginate-chitosan-blended nanocarrier induces apoptosis in human glioblastoma cells |
| - | in-vitro, | GBM, | U87MG |
| 4424- | SNP, | Understanding the prospective of nano-formulations towards the treatment of psoriasis |
| - | in-vivo, | PSA, | NA |
| 4433- | SNP, | Advancements in metal and metal oxide nanoparticles for targeted cancer therapy and imaging: Mechanisms, applications, and safety concerns |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Nor, | L02 |
| 4432- | SNP, | Emerging nanostructure-based strategies for breast cancer therapy: innovations, challenges, and future directions |
| - | Review, | NA, | NA |
| 4431- | SNP, | doxoR, | Oxidative Stress-Induced Silver Nano-Carriers for Chemotherapy |
| - | in-vitro, | BC, | 4T1 | - | in-vivo, | BC, | 4T1 | - | in-vitro, | Nor, | 3T3 |
| 4430- | SNP, | Evaluation of the Genotoxic and Oxidative Damage Potential of Silver Nanoparticles in Human NCM460 and HCT116 Cells |
| - | in-vitro, | Colon, | HCT116 | - | in-vitro, | Nor, | NCM460 |
| 4429- | SNP, | Comparative proteomic analysis reveals the different hepatotoxic mechanisms of human hepatocytes exposed to silver nanoparticles |
| - | in-vitro, | Liver, | HepG2 |
| 4428- | SNP, | p38 MAPK Activation, DNA Damage, Cell Cycle Arrest and Apoptosis As Mechanisms of Toxicity of Silver Nanoparticles in Jurkat T Cells |
| - | in-vitro, | AML, | Jurkat |
| 4427- | SNP, | Silver nanoparticles induce apoptosis and G2/M arrest via PKCζ-dependent signaling in A549 lung cells |
| - | in-vitro, | Lung, | A549 |
| 4426- | SNP, | Antiangiogenic properties of silver nanoparticles |
| - | Study, | NA, | NA |
| 4398- | SNP, | Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier |
| - | in-vitro, | Colon, | HT29 |
| 4423- | SNP, | Pongamia pinnata seed extract-mediated green synthesis of silver nanoparticle loaded nanogel for estimation of their antipsoriatic properties |
| - | in-vivo, | PSA, | NA |
| 4422- | SNP, | Bioengineering of Piper longum L. extract mediated silver nanoparticles and their potential biomedical applications |
| - | in-vitro, | Cerv, | HeLa |
| 4421- | SNP, | Effect of Biologically Synthesized Silver Nanoparticles on Human Cancer Cells |
| - | in-vitro, | Cerv, | NA |
| 4419- | SNP, | Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis |
| - | NA, | PSA, | NA |
| 4418- | SNP, | Nanocarriers for the topical treatment of psoriasis - pathophysiology, conventional treatments, nanotechnology, regulatory and toxicology |
| - | Human, | PSA, | NA |
| 4417- | SNP, | Caffeine-boosted silver nanoparticles target breast cancer cells by triggering oxidative stress, inflammation, and apoptotic pathways |
| - | in-vitro, | BC, | MDA-MB-231 |
| 4416- | SNP, | Efficacy of curcumin-synthesized silver nanoparticles on MCF-7 breast cancer cells |
| - | in-vitro, | BC, | MCF-7 |
| 2286- | SNP, | Short-term changes in intracellular ROS localisation after the silver nanoparticles exposure depending on particle size |
| - | in-vitro, | Nor, | 3T3 |
| 1907- | SNP, | GoldNP, | Cu, | In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Melanoma, | A375 | - | in-vitro, | Colon, | HCT15 | - | in-vitro, | Cerv, | HeLa |
| 1908- | SNP, | Exposure to Silver Nanoparticles Inhibits Selenoprotein Synthesis and the Activity of Thioredoxin Reductase |
| - | in-vitro, | Lung, | A549 |
| 2836- | SNP, | Gluc, | Glucose capped silver nanoparticles induce cell cycle arrest in HeLa cells |
| - | in-vitro, | Cerv, | HeLa |
| 1909- | SNP, | The Antibacterial Drug Candidate SBC3 is a Potent Inhibitor of Bacterial Thioredoxin Reductase |
| - | in-vivo, | Nor, | NA |
| 2205- | SNP, | Potential protective efficacy of biogenic silver nanoparticles synthesised from earthworm extract in a septic mice model |
| - | in-vivo, | Nor, | NA |
| 2206- | SNP, | RES, | ENHANCED EFFICACY OF RESVERATROL-LOADED SILVER NANOPARTICLE IN ATTENUATING SEPSIS-INDUCED ACUTE LIVER INJURY: MODULATION OF INFLAMMATION, OXIDATIVE STRESS, AND SIRT1 ACTIVATION |
| - | in-vivo, | Nor, | NA |
| 2207- | SNP, | TQ, | Protective effects of Nigella sativa L. seeds aqueous extract-based silver nanoparticles on sepsis-induced damages in rats |
| - | in-vivo, | Nor, | NA |
| 2208- | SNP, | Sepsis diagnosis and treatment using nanomaterials |
| - | Review, | NA, | NA |
| 2538- | SNP, | SDT, | Z, | Dual-functional silver nanoparticle-enhanced ZnO nanorods for improved reactive oxygen species generation and cancer treatment |
| - | Study, | Var, | NA | - | vitro+vivo, | NA, | NA |
| 2835- | SNP, | Gluc, | Carbohydrate functionalization of silver nanoparticles modulates cytotoxicity and cellular uptake |
| - | in-vitro, | Liver, | HepG2 |
| 2834- | SNP, | Gluc, | Electrochemical oxidation of glucose on silver nanoparticle-modified composite electrodes |
| - | Study, | NA, | NA |
| 1903- | SNP, | Novel Silver Complexes Based on Phosphanes and Ester Derivatives of Bis(pyrazol-1-yl)acetate Ligands Targeting TrxR: New Promising Chemotherapeutic Tools Relevant to SCLC Managemen |
| - | in-vitro, | Lung, | U1285 |
| 2539- | SNP, | SDT, | Combined effect of silver nanoparticles and therapeutical ultrasound on ovarian carcinoma cells A2780 |
| - | in-vitro, | Melanoma, | A2780S |
| 2287- | SNP, | Silver nanoparticles induce endothelial cytotoxicity through ROS-mediated mitochondria-lysosome damage and autophagy perturbation: The protective role of N-acetylcysteine |
| - | in-vitro, | Nor, | HUVECs |
| 2288- | SNP, | Silver Nanoparticle-Mediated Cellular Responses in Various Cell Lines: An in Vitro Model |
| - | Review, | Var, | NA |
| 403- | SNP, | RF, | Synergetic effects of silver and gold nanoparticles in the presence of radiofrequency radiation on human kidney cells |
| - | in-vitro, | NA, | HNK |
| 393- | SNP, | Green synthesized plant-based silver nanoparticles: therapeutic prospective for anticancer and antiviral activity |
| - | in-vitro, | NA, | HCT116 |
| 395- | SNP, | The apoptotic and genomic studies on A549 cell line induced by silver nitrate |
| - | in-vitro, | Lung, | A549 |
| 396- | SNP, | Systemic Evaluation of Mechanism of Cytotoxicity in Human Colon Cancer HCT-116 Cells of Silver Nanoparticles Synthesized Using Marine Algae Ulva lactuca Extract |
| - | in-vitro, | Colon, | HCT116 |
| 397- | SNP, | GEM, | Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment |
| - | in-vitro, | Ovarian, | A2780S |
| 398- | SNP, | Silver nanoparticles induced testicular damage targeting NQO1 and APE1 dysregulation, apoptosis via Bax/Bcl-2 pathway, fibrosis via TGF-β/α-SMA upregulation in rats |
| - | in-vivo, | Testi, | NA |
| 399- | SNP, | SIL, | Cytotoxic potentials of silibinin assisted silver nanoparticles on human colorectal HT-29 cancer cells |
| - | in-vitro, | CRC, | HT-29 |
| 400- | SNP, | MF, | Polyvinyl Alcohol Capped Silver Nanostructures for Fortified Apoptotic Potential Against Human Laryngeal Carcinoma Cells Hep-2 Using Extremely-Low Frequency Electromagnetic Field |
| - | in-vitro, | Laryn, | HEp2 |
| - | in-vitro, | BC, | MCF-7 |
| 1906- | SNP, | GoldNP, | Cu, | Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors |
| - | Review, | Var, | NA |
| 887- | SNP, | Antibacterial potential of silver nanoparticles against isolated urinary tract infectious bacterial pathogens |
| - | in-vitro, | UTI, | NA |
| 888- | SNP, | Antibacterial Effects of Silver Nanoparticles on the Bacterial Strains Isolated from Catheterized Urinary Tract Infection Cases |
| - | in-vivo, | UTI, | NA |
| 1406- | SNP, | The antioxidant effects of silver, gold, and zinc oxide nanoparticles on male mice in in vivo condition |
| - | in-vivo, | Nor, | NA |
| 1594- | SNP, | Citrate, | Silver Citrate Nanoparticles Inhibit PMA-Induced TNFα Expression via Deactivation of NF-κB Activity in Human Cancer Cell-Lines, MCF-7 |
| - | in-vitro, | BC, | MCF-7 |
| 1902- | SNP, | Modulation of the mechanism of action of antibacterial silver N-heterocyclic carbene complexes by variation of the halide ligand |
| - | in-vitro, | NA, | NA |
| 394- | SNP, | Anticancer activity of Moringa oleifera mediated silver nanoparticles on human cervical carcinoma cells by apoptosis induction |
| - | in-vitro, | Cerv, | HeLa |
| 1905- | SNP, | Evaluation of the effect of silver and silver nanoparticles on the function of selenoproteins using an in-vitro model of the fish intestine: The cell line RTgutGC |
| - | in-vivo, | Nor, | NA |
| 4388- | SNP, | Differential Cytotoxic Potential of Silver Nanoparticles in Human Ovarian Cancer Cells and Ovarian Cancer Stem Cells |
| - | in-vitro, | Cerv, | NA |
| 4378- | SNP, | Exploring silver nanoparticles for cancer therapy and diagnosis |
| - | Review, | Var, | NA |
| 4379- | SNP, | Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells |
| - | in-vitro, | CRC, | LoVo |
| 4380- | SNP, | Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways |
| - | in-vitro, | Lung, | A549 |
| 4381- | SNP, | Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells |
| - | in-vitro, | Liver, | HepG2 |
| 4382- | SNP, | Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism |
| - | in-vitro, | Nor, | RAW264.7 |
| 4383- | SNP, | Exploring the Potentials of Silver Nanoparticles in Overcoming Cisplatin Resistance in Lung Adenocarcinoma: Insights from Proteomic and Xenograft Mice Studies |
| - | in-vitro, | Lung, | A549 | - | in-vivo, | Lung, | A549 |
| 4385- | SNP, | Hepatoprotective effect of engineered silver nanoparticles coated bioactive compounds against diethylnitrosamine induced hepatocarcinogenesis in experimental mice |
| - | in-vitro, | Liver, | NA |
| 4386- | SNP, | Evaluation of hepatic cancer stem cells (CD73+, CD44+, and CD90+) induced by diethylnitrosamine in male rats and treatment with biologically synthesized silver nanoparticles |
| 4387- | SNP, | Attenuation of diethylnitrosamine (DEN) - Induced hepatic cancer in experimental model of Wistar rats by Carissa carandas embedded silver nanoparticles |
| - | in-vitro, | Liver, | NA |
| 4377- | SNP, | Interaction between silver nanoparticles of 20 nm (AgNP20 ) and human neutrophils: induction of apoptosis and inhibition of de novo protein synthesis by AgNP20 aggregates |
| - | in-vitro, | NA, | NA |
| 4389- | SNP, | Graphene Oxide-Silver Nanocomposite Enhances Cytotoxic and Apoptotic Potential of Salinomycin in Human Ovarian Cancer Stem Cells (OvCSCs): A Novel Approach for Cancer Therapy |
| - | in-vitro, | Ovarian, | NA |
| 4390- | SNP, | Therapeutic Potential of Cucumis melo (L.) Fruit Extract and Its Silver Nanopartciles Against DEN-Induced Hepatocellular Cancer in Rats |
| - | in-vivo, | Liver, | NA |
| 4391- | SNP, | Silver Nanoparticles Induce Apoptosis in HepG2 Cells through Particle-Specific Effects on Mitochondria |
| - | NA, | Liver, | HepG2 |
| 4392- | SNP, | Hepatocurative activity of biosynthesized silver nanoparticles fabricated using Andrographis paniculata |
| - | in-vivo, | LiverDam, | NA |
| 4393- | SNP, | Nanotoxic Effects of Silver Nanoparticles on Normal HEK-293 Cells in Comparison to Cancerous HeLa Cell Line |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Nor, | HEK293 |
| 4394- | SNP, | Silver nanoparticles provoke apoptosis of Dalton's ascites lymphoma in vivo by mitochondria dependent and independent pathways |
| - | in-vivo, | lymphoma, | NA |
| 4395- | SNP, | Hepatoprotective effect of silver nanoparticles synthesized using aqueous leaf extract of Rhizophora apiculata |
| - | in-vivo, | LiverDam, | NA |
| - | in-vitro, | OS, | MG63 |
| 4397- | SNP, | Synthesis and Characterization of Silver Nanoparticles from Rhizophora apiculata and Studies on Their Wound Healing, Antioxidant, Anti-Inflammatory, and Cytotoxic Activity |
| - | NA, | Wounds, | NA |
| 4367- | SNP, | Effects of Prolonged Silver Nanoparticle Exposure on the Contextual Cognition and Behavior of Mammals |
| - | in-vivo, | Nor, | NA |
| 4358- | SNP, | HPT, | Rad, | Silver nanocrystals mediated combination therapy of radiation with magnetic hyperthermia on glioma cells |
| - | in-vitro, | GBM, | U251 |
| 4359- | SNP, | Antimicrobial Silver Nanoparticles for Wound Healing Application: Progress and Future Trends |
| - | NA, | Wounds, | NA |
| 4360- | SNP, | Silver Nanoparticles as Real Topical Bullets for Wound Healing |
| - | Study, | Nor, | NA |
| 4361- | SNP, | GoldNP, | Biocompatible silver, gold and silver/gold alloy nanoparticles for enhanced cancer therapy: in vitro and in vivo perspectives |
| - | in-vivo, | Liver, | HepG2 |
| 4362- | SNP, | Enhancing Colorectal Cancer Radiation Therapy Efficacy using Silver Nanoprisms Decorated with Graphene as Radiosensitizers |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HT29 | - | in-vivo, | NA, | NA |
| 4363- | SNP, | Immunomodulatory properties of silver nanoparticles contribute to anticancer strategy for murine fibrosarcoma |
| - | in-vivo, | fibroS, | NA |
| 4364- | SNP, | Selective cytotoxicity of green synthesized silver nanoparticles against the MCF-7 tumor cell line and their enhanced antioxidant and antimicrobial properties |
| - | in-vitro, | BC, | MCF-7 |
| 4365- | SNP, | Biomedical Applications of Silver Nanoparticles: An Up-to-Date Overview |
| - | Review, | Var, | NA |
| 4366- | SNP, | Gut Dysbiosis and Neurobehavioral Alterations in Rats Exposed to Silver Nanoparticles |
| - | in-vivo, | Nor, | NA |
| 2837- | SNP, | Trojan-Horse Mechanism in the Cellular Uptake of Silver Nanoparticles Verified by Direct Intra- and Extracellular Silver Speciation Analysis |
| - | in-vitro, | NA, | NA |
| 4368- | SNP, | Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro |
| - | NA, | Nor, | NA |
| 4369- | SNP, | Silver nanoparticles induce p53-mediated apoptosis in human bronchial epithelial (BEAS-2B) cells |
| - | in-vitro, | Nor, | BEAS-2B |
| 4370- | SNP, | Effect of silver nanoparticles in the induction of apoptosis on human hepatocellular carcinoma (HepG2) cell line |
| - | in-vitro, | Liver, | HepG2 |
| 4371- | SNP, | Effects of Green Silver Nanoparticles on Apoptosis and Oxidative Stress in Normal and Cancerous Human Hepatic Cells in vitro |
| - | in-vitro, | Liver, | HUH7 |
| 4372- | SNP, | Negligible particle-specific toxicity mechanism of silver nanoparticles: the role of Ag+ ion release in the cytosol |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Lung, | A549 |
| 4373- | SNP, | In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells |
| - | in-vitro, | Liver, | HepG2 |
| 4374- | SNP, | Enhancing antitumor activity of silver nanoparticles by modification with cell-penetrating peptides |
| - | in-vitro, | BC, | MCF-7 |
| 4375- | SNP, | The cellular uptake and cytotoxic effect of silver nanoparticles on chronic myeloid leukemia cells |
| - | in-vitro, | AML, | K562 |
| 4376- | SNP, | Interaction of multi-functional silver nanoparticles with living cells |
| - | in-vitro, | Nor, | L929 | - | in-vitro, | Lung, | A549 |
| 343- | SNP, | Silver nanoparticles of different sizes induce a mixed type of programmed cell death in human pancreatic ductal adenocarcinoma |
| - | in-vitro, | PC, | PANC1 |
| 334- | SNP, | Silver-Based Nanoparticles Induce Apoptosis in Human Colon Cancer Cells Mediated Through P53 |
| - | in-vitro, | Colon, | HCT116 |
| 335- | SNP, | PDT, | Biogenic Silver Nanoparticles for Targeted Cancer Therapy and Enhancing Photodynamic Therapy |
| - | Review, | NA, | NA |
| 336- | SNP, | PDT, | Photodynamic ability of silver nanoparticles in inducing cytotoxic effects in breast and lung cancer cell lines |
| - | in-vitro, | BC, | MCF-7 |
| 337- | SNP, | immuno, | Silver nanoparticle induced immunogenic cell death can improve immunotherapy |
| - | Review, | NA, | NA |
| 338- | SNP, | Biogenic silver nanoparticles: In vitro and in vivo antitumor activity in bladder cancer |
| - | vitro+vivo, | Bladder, | 5637 |
| 339- | SNP, | Cancer cell specific cytotoxic potential of the silver nanoparticles synthesized using the endophytic fungus, Penicillium citrinum CGJ-C2 |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Melanoma, | A431 | - | in-vitro, | HCC, | HepG2 |
| 340- | SNP, | Screening bioactivities of Caesalpinia pulcherrima L. swartz and cytotoxicity of extract synthesized silver nanoparticles on HCT116 cell line |
| - | in-vitro, | CRC, | HCT116 |
| 341- | SNP, | Bioprospecting a native silver-resistant Bacillus safensis strain for green synthesis and subsequent antibacterial and anticancer activities of silver nanoparticles |
| - | in-vitro, | Liver, | HepG2 |
| 342- | SNP, | Silver nanoparticles; a new hope in cancer therapy? |
| - | Review, | NA, | NA |
| 333- | SNP, | HPT, | Enhancement effect of cytotoxicity response of silver nanoparticles combined with thermotherapy on C6 rat glioma cells |
| - | in-vivo, | GBM, | NA |
| 344- | SNP, | Cytotoxicity and ROS production of manufactured silver nanoparticles of different sizes in hepatoma and leukemia cells |
| - | in-vitro, | Liver, | HepG2 |
| 345- | SNP, | Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model |
| - | vitro+vivo, | lymphoma, | NA |
| 346- | SNP, | RSQ, | Investigating Silver Nanoparticles and Resiquimod as a Local Melanoma Treatment |
| - | in-vivo, | Melanoma, | SK-MEL-28 | - | in-vivo, | Melanoma, | WM35 |
| 347- | SNP, | The Role of Silver Nanoparticles in the Diagnosis and Treatment of Cancer: Are There Any Perspectives for the Future? |
| - | Review, | NA, | NA |
| 348- | SNP, | Induction of p53 mediated mitochondrial apoptosis and cell cycle arrest in human breast cancer cells by plant mediated synthesis of silver nanoparticles from Bergenia ligulata (Whole plant) |
| - | in-vitro, | BC, | MCF-7 |
| 349- | SNP, | Insight into the molecular mechanism, cytotoxic, and anticancer activities of phyto-reduced silver nanoparticles in MCF-7 breast cancer cell lines |
| - | in-vitro, | BC, | MCF-7 |
| 350- | SNP, | Cytotoxic and Apoptotic Effects of Green Synthesized Silver Nanoparticles via Reactive Oxygen Species-Mediated Mitochondrial Pathway in Human Breast Cancer Cells |
| - | in-vitro, | BC, | MCF-7 |
| 351- | SNP, | Study of antitumor activity in breast cell lines using silver nanoparticles produced by yeast |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | T47D |
| 352- | SNP, | Synthesis of silver nanoparticles (Ag NPs) for anticancer activities (MCF 7 breast and A549 lung cell lines) of the crude extract of Syzygium aromaticum |
| - | in-vitro, | BC, | MCF-7 |
| 322- | SNP, | Cisplatin, | Heterogeneous Responses of Ovarian Cancer Cells to Silver Nanoparticles as a Single Agent and in Combination with Cisplatin |
| - | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Ovarian, | SKOV3 | - | in-vitro, | Ovarian, | OVCAR-3 |
| 306- | SNP, | Cancer Therapy by Silver Nanoparticles: Fiction or Reality? |
| - | Analysis, | NA, | NA |
| 309- | SNP, | Interference of silver, gold, and iron oxide nanoparticles on epidermal growth factor signal transduction in epithelial cells |
| - | in-vitro, | NA, | A431 |
| 312- | SNP, | wortm, | Inhibition of autophagy enhances the anticancer activity of silver nanoparticles |
| - | vitro+vivo, | NA, | HeLa |
| 316- | SNP, | Endoplasmic reticulum stress: major player in size-dependent inhibition of P-glycoprotein by silver nanoparticles in multidrug-resistant breast cancer cells |
| - | in-vitro, | BC, | MCF-7 |
| 317- | SNP, | Autophagic effects and mechanisms of silver nanoparticles in renal cells under low dose exposure |
| - | in-vitro, | Kidney, | HEK293 |
| 318- | SNP, | Silver nanoparticles regulate autophagy through lysosome injury and cell hypoxia in prostate cancer cells |
| - | in-vitro, | Pca, | PC3 |
| 319- | SNP, | Endoplasmic reticulum stress signaling is involved in silver nanoparticles-induced apoptosis |
| 320- | SNP, | Silver nanoparticles induce endoplasmatic reticulum stress response in zebrafish |
| - | vitro+vivo, | NA, | HUH7 |
| 321- | SNP, | I-131 doping of silver nanoparticles platform for tumor theranosis guided drug delivery |
| - | in-vivo, | NA, | NA |
| 353- | SNP, | The mechanism of cell death induced by silver nanoparticles is distinct from silver cations |
| - | in-vitro, | BC, | SUM159 |
| 324- | SNP, | CPT, | Silver Nanoparticles Potentiates Cytotoxicity and Apoptotic Potential of Camptothecin in Human Cervical Cancer Cells |
| - | in-vitro, | Cerv, | HeLa |
| 325- | SNP, | Silver nanoparticles modulate ABC transporter activity and enhance chemotherapy in multidrug resistant cancer |
| 326- | SNP, | TSA, | Modulating chromatin structure and DNA accessibility by deacetylase inhibition enhances the anti-cancer activity of silver nanoparticles |
| - | in-vitro, | Cerv, | HeLa |
| 327- | SNP, | MS-275, | Combination Effect of Silver Nanoparticles and Histone Deacetylases Inhibitor in Human Alveolar Basal Epithelial Cells |
| - | in-vitro, | Lung, | A549 |
| 328- | SNP, | Rad, | Silver nanoparticles outperform gold nanoparticles in radiosensitizing U251 cells in vitro and in an intracranial mouse model of glioma |
| - | vitro+vivo, | GBM, | U251 |
| 329- | SNP, | Rad, | Enhancement of radiotherapy efficacy by silver nanoparticles in hypoxic glioma cells |
| - | in-vitro, | GBM, | U251 |
| 330- | SNP, | Rad, | Reactive oxygen species acts as executor in radiation enhancement and autophagy inducing by AgNPs |
| - | in-vitro, | GBM, | U251 |
| 331- | SNP, | Rad, | Silver nanoparticles: a novel radiation sensitizer for glioma? |
| - | vitro+vivo, | GBM, | NA |
| 332- | SNP, | Rad, | Enhancement of Radiosensitization by Silver Nanoparticles Functionalized with Polyethylene Glycol and Aptamer As1411 for Glioma Irradiation Therapy |
| - | in-vivo, | GBM, | NA |
| 383- | SNP, | In vitro and in vivo evaluation of anti-tumorigenesis potential of nano silver for gastric cancer cells |
| - | in-vitro, | GC, | MKN45 |
| 374- | SNP, | Silver nanoparticles selectively treat triple‐negative breast cancer cells without affecting non‐malignant breast epithelial cells in vitro and in vivo |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vivo, | NA, | NA |
| 375- | SNP, | ALA, | Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pancreatic Cancer |
| - | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | MIA PaCa-2 | - | in-vivo, | NA, | NA |
| 376- | SNP, | Antitumor activity of colloidal silver on MCF-7 human breast cancer cells |
| - | in-vitro, | BC, | MCF-7 |
| 377- | SNP, | Anticancer Action of Silver Nanoparticles in SKBR3 Breast Cancer Cells through Promotion of Oxidative Stress and Apoptosis |
| - | in-vitro, | BC, | SkBr3 |
| 378- | SNP, | Antitumor efficacy of silver nanoparticles reduced with β-D-glucose as neoadjuvant therapy to prevent tumor relapse in a mouse model of breast cancer |
| - | ex-vivo, | BC, | 4T1 |
| 379- | SNP, | Effects of green-synthesized silver nanoparticles on lung cancer cells in vitro and grown as xenograft tumors in vivo |
| - | in-vivo, | Lung, | H1299 |
| 380- | SNP, | QC, | CA, | Chit, | Quercetin- and caffeic acid-functionalized chitosan-capped colloidal silver nanoparticles: one-pot synthesis, characterization, and anticancer and antibacterial activities |
| - | in-vitro, | MG, | U118MG |
| 381- | SNP, | Silver Nanoparticles Exert Apoptotic Activity in Bladder Cancer 5637 Cells Through Alteration of Bax/Bcl-2 Genes Expression |
| - | in-vitro, | Bladder, | 5637 |
| 382- | SNP, | Investigation the apoptotic effect of silver nanoparticles (Ag-NPs) on MDA-MB 231 breast cancer epithelial cells via signaling pathways |
| - | in-vitro, | BC, | MDA-MB-231 |
| 373- | SNP, | Cytotoxic Potential and Molecular Pathway Analysis of Silver Nanoparticles in Human Colon Cancer Cells HCT116 |
| - | in-vitro, | Colon, | HCT116 |
| 384- | SNP, | Dual functions of silver nanoparticles in F9 teratocarcinoma stem cells, a suitable model for evaluating cytotoxicity- and differentiation-mediated cancer therapy |
| - | in-vitro, | Testi, | F9 |
| 385- | SNP, | Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment |
| - | in-vitro, | Hepat, | HepG2 | - | in-vitro, | Hepat, | WI38 |
| 386- | SNP, | Tam, | Synergistic anticancer effects and reduced genotoxicity of silver nanoparticles and tamoxifen in breast cancer cells |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
| 387- | SNP, | Silver nanoparticles induce mitochondria-dependent apoptosis and late non-canonical autophagy in HT-29 colon cancer cells |
| - | in-vitro, | Colon, | HT-29 |
| 388- | SNP, | Apoptotic efficacy of multifaceted biosynthesized silver nanoparticles on human adenocarcinoma cells |
| - | in-vitro, | BC, | MCF-7 |
| 389- | SNP, | Citrate, | Silver Citrate Nanoparticles Inhibit PMA-Induced TNFα Expression via Deactivation of NF-κB Activity in Human Cancer Cell-Lines, MCF-7 |
| - | in-vitro, | BC, | MCF-7 |
| 390- | SNP, | Anti-cancerous effect of albumin coated silver nanoparticles on MDA-MB 231 human breast cancer cell line |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vivo, | BC, | NA |
| 391- | SNP, | Silver nanoparticles inhibit VEGF-and IL-1β-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells |
| 392- | SNP, | Biogenic silver nanoparticles synthesized from Piper longum fruit extract inhibit HIF-1α/VEGF mediated angiogenesis in prostate cancer cells |
| 363- | SNP, | Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis |
| - | in-vitro, | neuroblastoma, | SH-SY5Y |
| 355- | SNP, | Cytotoxicity and Genotoxicity of Biogenic Silver Nanoparticles in A549 and BEAS-2B Cell Lines |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | NA, | BEAS-2B |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Bladder, | HTB-22 |
| 357- | SNP, | Hypoxia-mediated autophagic flux inhibits silver nanoparticle-triggered apoptosis in human lung cancer cells |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | L132 |
| 358- | SNP, | Preparation of triangular silver nanoparticles and their biological effects in the treatment of ovarian cancer |
| - | vitro+vivo, | Ovarian, | SKOV3 |
| 359- | SNP, | Anti-cancer & anti-metastasis properties of bioorganic-capped silver nanoparticles fabricated from Juniperus chinensis extract against lung cancer cells |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | HEK293 |
| 360- | SNP, | Moringa, | Cytotoxic and Genotoxic Evaluation of Biosynthesized Silver Nanoparticles Using Moringa oleifera on MCF-7 and HUVEC Cell Lines |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | HUVECs |
| 361- | SNP, | Annona muricata assisted biogenic synthesis of silver nanoparticles regulates cell cycle arrest in NSCLC cell lines |
| - | in-vitro, | Lung, | A549 |
| 362- | SNP, | Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer |
| - | vitro+vivo, | SCC, | SCC9 |
| 305- | SNP, | Activity and pharmacology of homemade silver nanoparticles in refractory metastatic head and neck squamous cell cancer |
| - | Case Report, | HNSCC, | NA |
| 364- | SNP, | Differential Action of Silver Nanoparticles on ABCB1 (MDR1) and ABCC1 (MRP1) Activity in Mammalian Cell Lines |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Hepat, | HepG2 | - | in-vitro, | CRC, | SW-620 |
| 365- | SNP, | Silver nanoparticles affect glucose metabolism in hepatoma cells through production of reactive oxygen species |
| - | in-vitro, | Hepat, | HepG2 |
| 366- | SNP, | Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis |
| - | in-vitro, | BC, | MCF-7 |
| 367- | SNP, | Presence of an Immune System Increases Anti-Tumor Effect of Ag Nanoparticle Treated Mice |
| - | in-vivo, | NA, | NA |
| 368- | SNP, | In vitro evaluation of silver nanoparticles on human tumoral and normal cells |
| - | in-vitro, | Var, | NA |
| 369- | SNP, | Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis |
| - | in-vitro, | Liver, | NA |
| 370- | SNP, | Differential genotoxicity mechanisms of silver nanoparticles and silver ions |
| - | in-vitro, | lymphoma, | TK6 |
| 371- | SNP, | Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549 |
| - | in-vitro, | Lung, | A549 |
| - | in-vitro, | Hepat, | HepG2 |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:153 Target#:% State#:% Dir#:%
wNotes=on sortOrder:rid,rpid